DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $824,684 | +1.1% | 3,324 | -2.1% | 0.13% | +2.4% |
| Q2 2023 | $815,387 | -4.2% | 3,397 | +0.6% | 0.13% | -5.9% |
| Q1 2023 | $851,102 | -5.0% | 3,377 | +0.0% | 0.14% | -5.6% |
| Q4 2022 | $896,178 | -3.9% | 3,376 | -6.5% | 0.14% | -11.7% |
| Q3 2022 | $933,000 | +1.3% | 3,611 | -0.6% | 0.16% | +5.2% |
| Q2 2022 | $921,000 | -15.1% | 3,632 | -1.8% | 0.15% | -7.8% |
| Q1 2022 | $1,085,000 | -11.3% | 3,697 | -0.5% | 0.17% | -22.3% |
| Q4 2021 | $1,223,000 | +17.8% | 3,716 | +9.0% | 0.22% | +21.5% |
| Q3 2021 | $1,038,000 | +19.7% | 3,409 | +5.5% | 0.18% | +30.1% |
| Q2 2021 | $867,000 | +70.3% | 3,230 | +42.9% | 0.14% | +63.9% |
| Q1 2021 | $509,000 | +0.2% | 2,260 | -1.1% | 0.08% | -4.6% |
| Q4 2020 | $508,000 | +4.3% | 2,286 | +1.2% | 0.09% | -5.4% |
| Q3 2020 | $487,000 | +20.2% | 2,260 | -1.3% | 0.09% | +22.7% |
| Q2 2020 | $405,000 | +27.8% | 2,290 | +0.0% | 0.08% | +8.7% |
| Q1 2020 | $317,000 | -9.7% | 2,289 | 0.0% | 0.07% | +15.0% |
| Q4 2019 | $351,000 | +51.9% | 2,289 | +42.8% | 0.06% | +62.2% |
| Q3 2019 | $231,000 | +0.9% | 1,603 | 0.0% | 0.04% | +2.8% |
| Q2 2019 | $229,000 | +4.1% | 1,603 | -3.7% | 0.04% | +2.9% |
| Q1 2019 | $220,000 | – | 1,664 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |